Hyro expands go-to-market leadership with Brant Castellow as Chief Revenue Officer and Yehuda Berkowitz as VP of Sales Development. Aaron Bours Chief Marketing Officer, Hyro Two proven commercial leaders join to scale Hyro's revenue organization as demand for agentic AI in healthcare continues to accelerate NEW YORK, July 29, 2026 /PRNewswire/ - Hyro, the leading Agentic Care Communications platform, today announced the appointment of Brant Castellow as Chief Revenue Officer and Yehuda Berkowitz as Vice President of Sales Development. Health systems have moved past piloting agentic AI and are now deploying it against more complex use cases across their operations. With more than 100 million patient conversations, Hyro is adding Castellow and Berkowitz to build out its commercial organization. Castellow brings more than 25 years of healthcare technology sales leadership to Hyro. He joins from Reveleer, most recently as Executive Vice President of Sales and Customer Success, where over five years he helped grow the value-based care technology company's ARR by six times, building and scaling an enterprise go-to-market organization through a period of rapid growth that included multiple acquisitions and significant new financing. Earlier in his career, he led and scaled sales organizations at Cerner, TractManager/symplr, PatientSafe Solutions, and Anodyne Health ahead of its acquisition by athenahealth. He holds a BSBA in Marketing from the University of West Florida. "I've spent my career helping providers and health plans adopt technology that changes how care is delivered. What drew me to Hyro is what the team has created: AI agents, purpose-built for healthcare, that take action inside the EHR and telephony systems these organizations already run, resolving scheduling, registration, and prescription requests end-to-end instead of just routing them," said Castellow. "That's the difference between technology that demos well and technology a health system will trust with its patient conversations. As we grow, I want our go-to-market motion to be judged the same way our AI agents are: by the quality of the experience it creates for the customer. I'm excited to bring Hyro's platform to more health systems, and to build a revenue team that keeps pace with what our customers and their patients need." As Chief Revenue Officer, Castellow will lead Hyro's revenue organization. He will focus on deepening relationships with existing health systems, expanding into new specialties and service lines within them, and extending Hyro's reach beyond the enterprise into mid-market health systems. Berkowitz joins from DealHub, where he owned the company's full pipeline-generation engine, architecting targets, operating model, and execution framework from the ground up, and leading three teams to double pipeline output within six months. Earlier, he built sales development functions at AppsFlyer and WalkMe, scaling them into engines that fed hundreds of millions in pipeline. He holds a BA from The Hebrew University of Jerusalem. "Health systems are under real pressure, and demand for what Hyro does is climbing fast. My job is to turn that into a growth engine: pipeline that's predictable, not lucky," said Berkowitz. "Systems beat heroics. Repeatable results come when marketing, sales development, and customer success all run from the same playbook, and building that is what drew me here. So did the team: the talent and drive are rare, and I want to help shape that into something the whole market feels." As Vice President of Sales Development, Berkowitz will build Hyro's sales development organization and align the broader go-to-market team around a single playbook. The appointments follow Hyro's June addition of Dr. Sindhu Pandit as VP of Clinical Product Strategy, extending a leadership expansion that now reaches across both clinical product and go-to-market. "Health systems are no longer asking whether agentic AI belongs in patient care. They're putting it to work in their most critical interactions, and that raises the bar for every partner they choose," said Israel Krush, CEO and Co-Founder of Hyro. "In Brant and Yehuda, we're adding two leaders who know how to turn momentum into lasting infrastructure: the people, the pipeline, and the workflows that scale a company without eroding trust. I expect them to strengthen our team and carry our platform to far more health systems, expanding access to care while easing the pressure on overstretched staff. Together, they'll help define Hyro's next phase of growth." Castellow and Berkowitz join at a pivotal moment for Hyro - explore open roles at hyro.ai/careers. Aaron Bours Chief Marketing Officer, Hyro Aaron is Hyro's Chief Marketing Officer a conversational AI expert with almost a decade of experience under his belt working on next-gen natural language-enabled technology, including Google Duplex. Aaron is a former New Yorker who now spends his days casually knowing where all the coolest spots in Tel Aviv are without ever really trying.

athenahealth has launched Mobile Charge Capture, an add-on for its AI-native athenaOne platform, to help ambulatory physicians record professional charges in real time whilst rounding across hospitals and care facilities. Offered through a partnership with HybridChart, the solution addresses delays between care delivery and charge entry that can lead to lost revenue and coding errors. Nearly 70 athenaOne customers already use HybridChart across specialties including cardiology, orthopaedics, and neurology. According to HybridChart customer polling and internal analytics, practices switching from paper-based systems to Mobile Charge Capture report average revenue gains of 8% to 10%, reflecting fewer missed charges and documentation errors. The mobile-first workflow aims to reduce reliance on memory and handwritten notes for documenting charges after patient encounters.

The Best AI medical note-taking platforms compared. Kayla Manthey July 23, 2026 Healthtech has emerged as an exciting sector in the UK AI startup market. While the consumer AI space has been dominated by AI chatbots and coding assistants, a smaller, niche market, ambient AI scribes, have raised significant funding, secured NHS-scale partnerships and have excelled in an area many AI products do not: show tangible return in investment. What issues are AI medical note-taking platforms solving? Writing and updating documents is one of the most time consuming aspects of a clinician's job. General Practitioners (GPs) and even hospital clinicians spend a large amount of time during a meeting typing to complete a document rather than engaging with the patient in front of them. AI scribing solutions are able to listen to the meeting using the voice of a clinician, complete a digital transcription and automatically generate a formatted clinical note for review and submission. The more advanced platforms go further still, drafting referral letters, suggesting clinical codes and writing directly back into systems like EMIS and SystmOne. How fast are AI systems in health-tech growing? From a startup viewpoint, these developments represent a rapid land grab opportunity. Within a year or two, several companies have gone from pilots to deploying their systems in several thousand practices, helped by venture capital and NHS partnerships. This is one of the few AI industries where the claim of working AI systems is substantiated by results of real hospital trials, rather than by vendor marketing. Basically, in a short space of time, the ambient scribe category has grown from a few initial pilots to a well-funded, genuinely competitive market. For those observing this sector from a startup or investment point of view, there are a few important trends can be identified: NHS guidance offered. NHS England has effectively opened a rapid adoption route, in that its guidance on AI-enabled ambient scribing products and the DTAC compliance framework, provide a clear, if not easy, path to large enterprise adoption for startups. This is something that many AI focus areas do not have. The role of Accurx Scribe. Distribution is becoming as important as the underlying model. Backed by venture capital, the well-known software, Accurx Scribe, advantage isn't necessarily technical superiority, but it's that Accurx already sits inside roughly 98% of UK GP practices, turning a cold-start adoption problem into a feature toggle. How competitors are entering the market. Major competitors are on the move. Epic has introduced its own version of ambient scribe technology by utilising Microsoft's Dragon AI and Cosmos data Platform and athenahealth has introduced ambient AI for free in the US. This is the classic example of a successful startup-market trend. Once the startup has shown that a product category has value, the big platform companies, in this case the competitors, come in to monopolise it. What to look for in an AI medical scribe. Before assessing individual platforms, it is important to identify what differentiates a quality AI scribe from an average one. Some simple questions to use are as followed: For Clinical Accuracy: Can the scribe accurately discern what information is pertinent and what information is not? EHR Integration: Can the scribe write directly into EHR systems like EMIS, SystmOne, or Epic? Or does the scribe require copy and paste? Regulatory Status: In the UK, this includes the scribe being MHRA registered, DTAC compliant and having a DCB0129/0160 clinical safety case. Template Flexibility: Can the scribe adjust how clinical notes are formatted for different specialties? Data Handling Process: Does the scribe process and then discard audio? What is the scribe's data governance policy? Cost and Deployment Model: Does the scribe offer a free subscription for individual use? Or is the scribe only available via large scale practice or trust contracts? Top AI medical scribes in the space. Taking all mentioned above into consideration, including clinical accuracy, regulatory status and data handling processes, below are the leading platforms in the space: Accurx Scribe (powered by tandem health). Accurx Scribe has a distribution advantage that's hard for competitors to match: it's built into the Accurx platform already used by the vast majority of UK GP practices for patient communication, meaning many practices may already have access without a separate procurement process. * Best for: Practices already using Accurx that want documentation added with minimal additional onboarding * Strengths: Direct EMIS and SystmOne write-back, links transcripts to the initial patient triage request, MHRA Class I registered and built for ephemeral audio processing * Considerations: As a newer, feature-within-a-platform offering, its scribe-specific functionality is less mature than dedicated tools like Heidi or TORTUS Freed. Freed has built a reputation as a lightweight, affordable option, often highlighted for its accessibility to solo practitioners and small teams who want a straightforward scribe without complex configuration or enterprise procurement. * Best for: Solo practitioners and smaller practices wanting a simple, low-cost entry point * Strengths: Fast setup, browser-based EHR compatibility via a Chrome extension and a relatively simple pricing structure * Considerations: Lacks the depth of specialty-specific customisation and institutional governance features found in NHS-deployed tools Nabla. Nabla is an ambient AI medical assistant known for fast note generation and broad multilingual support, making it a strong option for clinicians working with linguistically diverse patient populations. * Best for: Clinicians wanting quick note turnaround and multilingual consultation support * Strengths: Real-time transcription, automatic SOAP note generation tailored to a clinician's writing style, direct EHR import and a HIPAA-compliant architecture * Considerations: Positioned more toward general clinical documentation than deep specialty-specific templating Abridge, Nuance DAX Copilot and enterprise US platforms. For context, it's worth noting the enterprise end of the market, even though UK adoption of these specific tools remains limited. Abridge and Nuance DAX Copilot are widely used across large US health systems with deep Epic integration, priced accordingly at the enterprise level. Neither currently offers the same depth of Epic-style integration within UK systems that TORTUS, Heidi and Accurx Scribe now offer for EMIS and SystmOne. So, it is important to understand that the 'best' platform often depends heavily on which healthcare system and EHR a clinician is actually working within.